NCT05958199 2025-06-27A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7NextPoint Therapeutics, Inc.Phase 1 Suspended131 enrolled
NCT04714983 2024-04-09DNX-2440 for Resectable Colorectal Liver MetastasisDNAtrix, Inc.Phase 1 Suspended30 enrolled
NCT00443573 2008-05-07Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon CancerARCA Biopharma, Inc.Phase 1/2 Suspended100 enrolled